Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QIAGEN N.V. (QGEN : NYSE)

• Company Description    QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia. Number of Employees: 5,654

• Price / Volume Information    Yesterday's Closing Price: $35.17 Daily Weekly Monthly 20 Day Moving Average: 2,645,715 shares Shares Outstanding: 206.07 (millions) Market Capitalization: $7,247.66 (millions) Beta: 0.64 52 Week High: $57.82 52 Week Low: $32.53 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.37% -11.90% 12 Week -28.34% -33.76% Year To Date -25.70% -32.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL HULSTERWEG 82 - PL VENLO,P7 5912 NLD ph: 31-77-355-6600 fax: 31-77-355-6658 daniel.wendorff@qiagen.com http://www.qiagen.com

• General Corporate Information    Officers Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Toralf Haag - Supervisory Director Eva Pisa - Supervisory Director Metin Colpan - Supervisory Director Peer Information QIAGEN N.V. (CORR.) QIAGEN N.V. (RSPI) QIAGEN N.V. (CGXP) QIAGEN N.V. (BGEN) QIAGEN N.V. (GTBP) QIAGEN N.V. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: N72482156 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 206.07 Most Recent Split Date: 1.00 (0.95:1) Beta: 0.64 Market Capitalization: $7,247.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.75% Current Fiscal Quarter EPS Consensus Estimate: $0.60 Indicated Annual Dividend: $0.26 Current Fiscal Year EPS Consensus Estimate: $2.43 Payout Ratio: 0.11 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.09 Estmated Long-Term EPS Growth Rate: 4.13% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 14.46 Trailing 12 Months: 14.45 PEG Ratio: 3.50 Price Ratios Price/Book: 2.18 Price/Cash Flow: 10.33 Price / Sales: 3.45 EPS Growth vs. Year Ago Period: -6.73% vs. Previous Quarter: -12.90% Sales Growth vs. Year Ago Period: 1.83% vs. Previous Quarter: -8.90% ROE 03/31/26 - 14.40 12/31/25 - 14.56 09/30/25 - 14.80 ROA 03/31/26 - 8.40 12/31/25 - 8.62 09/30/25 - 8.86 Current Ratio 03/31/26 - 3.21 12/31/25 - 3.90 09/30/25 - 2.60 Quick Ratio 03/31/26 - 2.57 12/31/25 - 3.31 09/30/25 - 2.30 Operating Margin 03/31/26 - 24.47 12/31/25 - 24.97 09/30/25 - 25.25 Net Margin 03/31/26 - 19.16 12/31/25 - 20.33 09/30/25 - 19.58 Pre-Tax Margin 03/31/26 - 21.75 12/31/25 - 23.46 09/30/25 - 24.48 Book Value 03/31/26 - 16.17 12/31/25 - 17.89 09/30/25 - 17.28 Inventory Turnover 03/31/26 - 2.67 12/31/25 - 2.71 09/30/25 - 2.67 Debt-to-Equity 03/31/26 - 0.49 12/31/25 - 0.44 09/30/25 - 0.45 Debt-to-Capital 03/31/26 - 33.08 12/31/25 - 30.45 09/30/25 - 30.84

Powered by Zacks Investment Research ©